Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

On Bayesian methods of exploring qualitative interactions for targeted treatment.

Statistics in medicine - 10 Dec 2012

Chen Wei, Ghosh Debashis, Raghunathan Trivellore E, Norkin Maxim, Sargent Daniel J, Bepler Gerold

Abstract excerpt

Providing personalized treatments designed to maximize benefits and minimizing harms is of tremendous current medical interest. One problem in this area is the evaluation of the interaction between the treatment and other predictor variables. Treatment effects in subgroups having the same direction but different magnitudes are called quantitative interactions, whereas those having opposite directions in subgroups...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal, Humanized
Share to Carboplatin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cetuximab

Share to Clinical Trials, Phase III as Topic

Share to Gefitinib

Share to Paclitaxel

Share to Quinazolines

Share to Regression Analysis

Source

Open in PubMed Open full text

Identifiers

PMID: 22733620
DOI: 10.1002/sim.5429
PMCID: PMC3528020

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

On Bayesian methods of exploring qualitative interactions for targeted treatment.PMID 22733620Read ↗

A hierarchical Bayes model for biomarker subset effects in clinical trialsSemantic proximity Read ↗

The Call for Progress in Evidence-Based MedicineSemantic proximity Read ↗

An Evidenced-Based Prior for Estimating the Treatment Effect of Phase III Randomized Trials in OncologySemantic proximity Read ↗

Predicting Individual Responses in Phase I Oncology Trials Using Routinely Collected Clinical BiomarkersSemantic proximity Read ↗

Favoring the hierarchical constraint in penalized survival models for randomized trials in precision medicineSemantic proximity Read ↗

A general framework for using two-stage meta-analysis with individual participant data to predict individualized treatment effectsSemantic proximity Read ↗

Bayesian Networks with Interpretable Summary Indexes for Modeling Clinicians’ Decision-Making in Treatment Recommendation for Mental DisordersSemantic proximity Read ↗

Using the Bayesian credible subgroups method to identify populations benefiting from treatment: An application to the Look AHEAD trialSemantic proximity Read ↗

Evaluating predictive biomarkers for a binary outcome with linear versus logistic regression – Practical recommendations for the choice of the modelSemantic proximity Read ↗

Quantifying Treatment Benefit in Molecular Subgroups to Assess a Predictive Biomarker.Semantic proximity Read ↗

Integrative variable selection via Bayesian model uncertainty.Semantic proximity Read ↗

Virtual Trials: Causally-validated treatment effects efficiently learned from an observational cancer registrySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.